Signal peptide peptidase forms a homodimer that is labeled by an active site-directed γ-secretase inhibitor

被引:75
作者
Nyborg, AC
Kornilova, AY
Jansen, K
Ladd, TB
Wolfe, MS
Golde, TE
机构
[1] Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA
[2] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M309305200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Presenilin (PS) is the presumptive catalytic component of the intramembrane aspartyl protease gamma-secretase complex. Recently a family of presenilin homologs was identified. One member of this family, signal peptide peptidase (SPP), has been shown to be a protease, which supports the hypothesis that PS and presenilin homologs are related intramembrane-cleaving aspartyl proteases. SPP has been reported as a glycoprotein of similar to 45 kDa. Our initial characterization of SPP isolated from human brain and cell lines demonstrated that SPP is primarily present as an SDS-stable similar to 95-kDa protein on Western blots. Upon heating or treatment of this similar to95-kDa SPP band with acid, a similar to45-kDa band could be resolved. Co-purification of two different epitope-tagged forms of SPP from a stably transfected cell line expressing both tagged versions demonstrated that the similar to 95-kDa band is a homodimer of SPP. Pulse-chase metabolic labeling studies demonstrated that the SPP homodimer assembles rapidly and is metabolically stable. In a glycerol velocity gradient, SPP sedimented from similar to 100 - 200 kDa. Significantly the SPP homodimer was specifically labeled by an active site-directed photoaffinity probe (III-63) for PS, indicating that the active sites of SPP and PS/gamma-secretase are similar and providing strong evidence that the homodimer is functionally active. Collectively these data suggest that SPP exists in vivo as a functional dimer.
引用
收藏
页码:15153 / 15160
页数:8
相关论文
共 36 条
[1]   Homodimerization of presenilin N-terminal fragments is affected by mutations linked to Alzheimer's disease [J].
Cervantes, S ;
González-Duarte, R ;
Marfany, G .
FEBS LETTERS, 2001, 505 (01) :81-86
[2]   Presenilin and nicastrin regulate each other and determine amyloid β-peptide production via complex formation [J].
Edbauer, D ;
Winkler, E ;
Haass, C ;
Steiner, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) :8666-8671
[3]   Reconstitution of γ-secretase activity [J].
Edbauer, D ;
Winkler, E ;
Regula, JT ;
Pesold, B ;
Steiner, H ;
Haass, C .
NATURE CELL BIOLOGY, 2003, 5 (05) :486-488
[4]   Amyloid-lowering isocoumarins are not direct inhibitors of γ-secretase [J].
Esler, WP ;
Das, C ;
Campbell, WA ;
Kimberly, WT ;
Kornilova, AY ;
Diehl, TS ;
Ye, WJ ;
Ostaszewski, BL ;
Xia, WM ;
Selkoe, DJ ;
Wolfe, MS .
NATURE CELL BIOLOGY, 2002, 4 (05) :E110-E111
[5]   Activity-dependent isolation of the presenilin-γ-secretase complex reveals nicastrin and a γ substrate [J].
Esler, WP ;
Kimberly, WT ;
Ostaszewski, BL ;
Ye, WJ ;
Diehl, TS ;
Selkoe, DJ ;
Wolfe, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :2720-2725
[6]   Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1 [J].
Esler, WP ;
Kimberly, WT ;
Ostaszewski, BL ;
Diehl, TS ;
Moore, CL ;
Tsai, JY ;
Rahmati, T ;
Xia, WM ;
Selkoe, DJ ;
Wolfe, MS .
NATURE CELL BIOLOGY, 2000, 2 (07) :428-434
[7]   Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease [J].
Evin, G ;
Sharples, RA ;
Weidemann, A ;
Reinhard, FBM ;
Carbone, V ;
Culvenor, JG ;
Holsinger, RMD ;
Sernee, MF ;
Beyreuther, K ;
Masters, CL .
BIOCHEMISTRY, 2001, 40 (28) :8359-8368
[8]   aph-1 and pen-2 are required for notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation [J].
Francis, R ;
McGrath, G ;
Zhang, JH ;
Ruddy, DA ;
Sym, M ;
Apfeld, J ;
Nicoll, M ;
Maxwell, M ;
Hai, B ;
Ellis, MC ;
Parks, AL ;
Xu, W ;
Li, JH ;
Gurney, M ;
Myers, RL ;
Himes, CS ;
Hiebsch, R ;
Ruble, C ;
Nye, JS ;
Curtis, D .
DEVELOPMENTAL CELL, 2002, 3 (01) :85-97
[9]   Presenilins as therapeutic targets for the treatment of Alzheimer's disease [J].
Golde, TE ;
Younkin, SG .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (06) :264-269
[10]  
GOLDE TE, 2003, SCI STKE